4//SEC Filing
Haurwitz Rachel E. 4
Accession 0001628280-24-006421
CIK 0001619856other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 5:18 PM ET
Size
8.2 KB
Accession
0001628280-24-006421
Insider Transaction Report
Form 4
Haurwitz Rachel E.
DirectorPresident and CEO
Transactions
- Award
Option to purchase Common Stock
2024-02-20+546,950→ 546,950 totalExercise: $6.81Exp: 2034-02-19→ Common Stock (546,950 underlying) - Award
Common Stock
2024-02-20+118,700→ 158,700 total
Holdings
- 3,349,395(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]This reflects restricted stock units ("RSUs") that vest in four equal annual installments beginning on February 20, 2025, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date.
- [F2]Shares are held by The City Canyon Family Trust dated May 31, 2021, of which the Reporting Person is a Co-Trustee with her spouse.
- [F3]25% of the options will vest upon the one-year anniversary of the grant date, February 20, 2025, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.
Documents
Issuer
Caribou Biosciences, Inc.
CIK 0001619856
Entity typeother
Related Parties
1- filerCIK 0001670579
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 5:18 PM ET
- Size
- 8.2 KB